Open Access Open Access  Restricted Access Subscription Access

Classification Such as Glucocorticoids, Cytostatics, Antibodies, Action of Drugs on Immunophilins and Treatment as Well as Side Effects of Immuno Suppressive Drugs

Muralinath E., Sony Sharlet E., Madhavi Latha C., Ramadevi Ch., Sheethal U., Guruprasad M., Karthik Jayanth Y., Renuka. U.

Abstract


The adrenal cortex produces powerful steroid hormones called glucocorticoids. They are crucial for controlling immunological response, metabolism, and stress response. Because of their potent anti-inflammatory and immunosuppressive properties, synthetic counterparts (such as prednisone and dexamethasone) are frequently recommended; nevertheless, prolonged use may result in metabolic adverse effects.


Full Text:

PDF

References


Meneghini, M., Bestard, O., & Grinyó, J. M. (2021). Immunosuppressive drugs: Modes of action. Best Practice & Research Clinical Gastroenterology, 54, 101757. https://doi.org/10.1016/j.bpg.2021.101757

Rathee, P., Chaudhary, H., Rathee, S., Rathee, D., & Kumar, V. (2013). Immunosuppressants: A review. The Pharma Innovation Journal, 1(12), 90–95.

Mathias, C. B., & McAleer, J. P. (2019). Transplantation: Immunologic principles and pharmacologic agents. In Pharmacology of immunotherapeutic drugs (pp. 251–276). Springer. https://doi.org/10.1007/978-3-030-10811-3_11

Caramori, G., Mumby, S., Girbino, G., Chung, K. F., & Adcock, I. M. (2019). Corticosteroids. In M. J. Parnham (Ed.), Nijkamp and Parnham's principles of immunopharmacology (3rd ed., pp. 661–688). Springer. https://doi.org/10.1007/978-3-030-10811-3_31

Gabrielli, F., Bernasconi, E., Toscano, A., Avossa, A., Cavicchioli, A., Andreone, P., & Gitto, S. (2025). Side effects of immunosuppressant drugs after liver transplant. Pharmaceuticals, 18(3), 342. https://doi.org/10.3390/ph18030342

Krensky, A. M., Vincenti, F., & Bennett, W. M. (2006). Immunosuppressants, tolerogens, and immunostimulants. In L. L. Brunton, J. S. Lazo, & K. L. Parker (Eds.), Goodman & Gilman's the pharmacological basis of therapeutics (11th ed., pp. 1405–1431). McGraw-Hill.

Suresh, C., & M., N. P. (2020). Immunomodulators. International Journal of Pharmaceutical Research, 12(Suppl. 2), 1968–1974.

Patil, U. S., Jaydeokar, A. V., & Bandawane, D. D. (2012). Immunomodulators: A pharmacological review. International Journal of Pharmacy and Pharmaceutical Sciences, 4(1), 30–36.

Hall, P. D., Goust, J. M., & Virella, G. (2001). Immune system modulators. In G. Virella (Ed.), Medical immunology (5th ed., pp. 473–486). Marcel Dekker.

Stepkowski, S. M. (2000). Molecular targets for existing and novel immunosuppressive drugs. Expert Reviews in Molecular Medicine, 2(4), 1–23. https://doi.org/10.1017/S1462399400001815

Kanatoula, D. D., Bodner, E., Ghoreschi, K., Meier, K., & Solimani, F. (2024). Non-biologic immunosuppressive drugs for inflammatory and autoimmune skin diseases. Journal der Deutschen Dermatologischen Gesellschaft, 22(3), 400–421. https://doi.org/10.1111/ddg.15310

Moutsopoulos, H. M., & Zampeli, E. (2020). Medications, therapeutic modalities, and regimens used in the management of rheumatic diseases. In Immunology and rheumatology in questions (pp. 205–243). Springer. https://doi.org/10.1007/978-3-030-22094-5_12

Cieza, N. E., Porubsky, M., & Jie, T. (2015). Advances in immunosuppressive therapy. In Technological advances in surgery, trauma and critical care (pp. 545–559). Springer. https://doi.org/10.1007/978-1-4939-2507-7_34

Mukherjee, S., & Mukherjee, U. (2009). A comprehensive review of immunosuppression used for liver transplantation. Journal of Transplantation, 2009, Article 701464. https://doi.org/10.1155/2009/701464

Menon, D., & Bril, V. (2022). Pharmacotherapy of generalized myasthenia gravis with special emphasis on newer biologicals. Drugs, 82(8), 865–887. https://doi.org/10.1007/s40265-022-01709-7


Refbacks

  • There are currently no refbacks.